GenScript ProBio logo — A comprehensive R&D and production platform offering complet...

GenScript ProBio

A comprehensive R&D and production platform offering complete solutions for cell and gene therapy, vaccine discovery, and antibody protein drugs.

Founded 2002 1001-5000 employees Series C Total: $220.00M Biopharma, Pharmaceutical

General Information

Company Name GenScript ProBio
Founded Year 2002
Employees 1001-5000
Industries Biopharma, Pharmaceutical
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with GenScript ProBio. To contact GenScript ProBio, visit genscriptprobio.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GenScript ProBio compare?

A PDF of GenScript ProBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GenScript ProBio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GenScript ProBio

GenScript ProBio, a leading biopharmaceutical R&D and production platform, offers comprehensive solutions for cell and gene therapy, vaccine discovery, and antibody protein drugs. Established in 2002, the company has made significant strides in the Biopharma and Pharmaceutical industries. In its latest funding round, the company secured an impressive $220.00M Series C investment on 18 January 2023. Notably, this round saw participation from a diverse group of investors including HighLight Capital, New Alliance Capital, Legend Capital, GF Xinde, Hillhouse Investment, 兴业资产管理股份有限公司, Huatai Zijin Investment, and Xiamen C&D Corporation. GenScript ProBio's comprehensive range of services, encompassing end-to-end support for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, and antibody protein drugs, positions the company as a significant player in the biopharmaceutical space. With a strong track record and support from notable investors, the company is well-positioned to continue its growth and innovation in the burgeoning field of biopharmaceuticals.

Business keywords: Biopharmaceutical R&D, Cell and gene therapy, Vaccine discovery, Antibody protein drugs, CDMO, Advanced Therapies, Biologics Development, Outsource Manufacturing, Viral Vector Manufacturing, Protein Antibody Drug Development, Protein Engineering

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $220.00M 8
HighLight Capital, New Alliance Capital +6
18 Jan 2023

GenScript ProBio Alternatives & Competitors

View All Alternatives
GenScript ProBio vs
ProBio
ProBio United States

Manufacturing Life-Changing Therapies

Series C
246 employees
Biopharma, Biotechnology
GenScript ProBio vs

Empowering global biopharma with world-class cell culture and GMP production services.

Series A
Biopharma, Biotechnology
GenScript ProBio vs

Empowering Pharmaceutical Innovation, Improving Quality of Life, Safeguarding Human Health

Series B
80 employees
Biopharma, Biotechnology

FAQ About GenScript ProBio

A comprehensive R&D and production platform offering complete solutions for cell and gene therapy, vaccine discovery, and antibody protein drugs.
GenScript ProBio was founded in 2002.
GenScript ProBio operates in Biopharma and Pharmaceutical. Its work centres on Biopharmaceutical R&D, Cell and gene therapy, Vaccine discovery and Antibody protein drugs.
GenScript ProBio has approximately 1001-5000 employees.
GenScript ProBio has completed 1 funding round, raising a total of $220.00M. The latest funding stage is Series C.
Top alternatives and competitors to GenScript ProBio include ProBio, BioInno, BioDlink(TOT BIOPHARM), CoJourney, 64x Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GenScript ProBio and ProBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GenScript ProBio, https://bouncewatch.com/company/genscript-probio, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes